View up-to-date information on Denali Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
27 May 2022 | PharmEnable Enters into Collaboration with Denali Therapeutics | Partnership | - |
PharmEnable Ltd
Denali Therapeutics Inc |
28 Feb 2022 | Denali Therapeutics to Raise up to USD400 Million in Public Offering of Shares | Equity Offering | - |
Denali Therapeutics Inc |
13 Oct 2020 | Denali Therapeutics Exercises License Option Agreement with Secarna Pharma | Licensing Agreement |
Denali Therapeutics Inc
|
Secarna Pharmaceuticals GmbH & Co KG
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer